We aim to examine the effects of Vitamin D supplementation on cardiorespiratory fitness and adiposity in overweight men.
Conditions
Interventions
Trade Name: D-vitamin Olja ACO 80 IE/drop, oral drops, solution.
Pharmaceutical Form: Oral solution
Pharmaceutical form of the placebo: Oral drops, solution
Route of administration of the placebo: Ora
Sponsors
Örebro University Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Age: 18-70 2. Sex: Male 3. Body Mass Index (BMI) > 25 kg/m2 4. Vitamin D deficiency (25-OH D-vitamin =65 years) yes F.1.3.1 Number of subjects for this age range 2
Exclusion criteria
Exclusion criteria: 1. Heart disease that requires treatment 2. Serious lung disease that requires treatment 3. Ongoing Vitamin D supplementation 4. Hypercalcemia (albumin corrected calcium > 2.55 mmol/L) 5. Inability to perform ergospirometry
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To examine if and how Vitamin D supplementation influences the cardiorespiratory fitness and the fat mass in overweight men with vitamin D deficiency.;Secondary Objective: Not applicable.;Primary end point(s): Change in cardiorespiratory fitness and fat mass after Vitamin D supplementation.;Timepoint(s) of evaluation of this end point: The intervention (Vitamin D supplementation) will last for six months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): Not applicable.;Timepoint(s) of evaluation of this end point: Not applicable. | — |
Countries
Sweden
Contacts
Public ContactÖrebro University Hospital
Örebro University Hospital
Outcome results
None listed